Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€16.20
28.04.24
€10.00
30.09.25
-44.26%
16:11

Could be very worthwhile Investment >20% year
BiotechBee 
28.04.24 70%
sell
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€14.14
26.04.24
-
26.04.25
14.57%
27.04.24

Risky Investment
Wolf_of_WS 
26.04.24 50%
sell
Realpha Tech Corp.

Start price
Target price
Perf. (%)
€1.48
25.04.24
-
25.04.25
-28.28%
28.04.24

blaugold 
25.04.24 50%
sell
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.96
24.04.24
-
24.04.25
35.45%
26.04.24

Could be worthwhile Investment >10% per year
Vassago1 
24.04.24 50%
sell
Realpha Tech Corp.

Start price
Target price
Perf. (%)
€0.96
24.04.24
-
24.04.25
53.93%
25.04.24

Wolf_of_WS 
24.04.24 50%
buy
Arcadium Lithium Plc

Start price
Target price
Perf. (%)
€3.68
23.04.24
€5.00
23.04.25
2.17%
27.04.24

skatcup 
23.04.24 80%
buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.70
19.04.24
-
19.04.25
26.17%
28.04.24

Bankster 
19.04.24 50%
buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.70
19.04.24
-
19.04.25
26.17%
27.04.24

Very good company culture
Could be worthwhile Investment >10% per year
Few uniques
me8 
19.04.24 0%
buy
Freeport Resources Inc.

Start price
Target price
Perf. (%)
€0.039
18.04.24
€0.000
18.04.25
10.26%
16:49

Traumtanz 
18.04.24 50%
buy
China Sxt Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.13
17.04.24
-
17.04.25
-14.13%
28.04.24

thomasw 
17.04.24 50%
buy
Sofi Technologies Inc.

Start price
Target price
Perf. (%)
€6.60
17.04.24
-
-
17.04.24

WatchMen 
17.04.24 50%
buy
China Sxt Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.54
16.04.24
-
16.04.25
-36.88%
28.04.24

Bankster 
16.04.24 50%
buy
China Sxt Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.10
16.04.24
-
16.04.25
-53.71%
27.04.24

me8 
16.04.24 0%
sell
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.24
16.04.24
-
16.04.25
14.52%
17.04.24

WatchMen 
16.04.24 50%
buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.22
15.04.24
-
15.04.25
7.38%
28.04.24

Bankster 
15.04.24 50%
sell
Globe Life Inc.

Start price
Target price
Perf. (%)
€53.00
15.04.24
-
12.04.25
13.21%
17.04.24

WatchMen 
15.04.24 50%
sell
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.45
15.04.24
€3.00
22.03.25
12.18%
17.04.24

WatchMen 
15.04.24 50%
buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.50
15.04.24
-
15.04.25
-12.67%
27.04.24

me8 
15.04.24 0%
buy
Addex Therapeutics Sa

Start price
Target price
Perf. (%)
€22.40
15.04.24
€35.00
29.03.26
-43.30%
12:15

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 70%
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.54
15.04.24
-
15.04.25
-13.13%
27.04.24

Could be worthwhile Investment >10% per year
Normal challenges to pay loans and raise capital
EBIT growth >5% per year expected
High dividend yield expected
kostojunior 
15.04.24 60%
buy
Coupang Inc.

Start price
Target price
Perf. (%)
€20.35
15.04.24
€33.00
15.04.25
6.41%
27.04.24

positive Cash Flow expected
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
kostojunior 
15.04.24 80%
buy
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.10
15.04.24
-
15.04.25
45.95%
28.04.24

quelbe60 
15.04.24 50%
buy
Msp Recovery Inc.

Start price
Target price
Perf. (%)
€1.06
15.04.24
-
15.04.25
-16.04%
28.04.24

michaelkr 
15.04.24 50%
sell
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.10
14.04.24
-
14.04.25
45.95%
28.04.24

blaugold 
14.04.24 50%
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.50
14.04.24
€1.00
14.04.25
12.53%
17.04.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Traumtanz 
14.04.24 50%